Escitalopram Oxalate Tablets I.P.
Shesto (Escitalopram Oxalate Tablets I.P.) contains the SSRI salt escitalopram oxalate, the active S-enantiomer of citalopram. Depression and anxiety disorders are linked to reduced serotonin signaling in brain circuits that regulate mood, worry, sleep, and concentration. Escitalopram selectively blocks the serotonin transporter (SERT), increasing serotonin availability at the synapse and gradually restoring balance in these circuits. Compared with many older antidepressants, SSRIs like escitalopram have minimal anticholinergic or cardiac effects at usual doses and are generally well tolerated. Early improvements in sleep, energy, and anxiety can appear in one to two weeks, with full benefit typically developing over four to six weeks of regular dosing.
Shesto (escitalopram oxalate) is prescribed for major depressive disorder and generalized anxiety disorder. Based on a clinician’s judgment and local guidance, it may also be used for panic disorder, social anxiety disorder, obsessive–compulsive disorder, and post-traumatic stress disorder when an SSRI is appropriate.